Valuation: IRADIMED CORPORATION

Market Cap 1.05B 916M 865M 785M 1.47B 101B 1.48B 10.36B 4B 51.23B 3.94B 3.86B 165B P/E 2026 *
42.8x
P/E 2027 * 37x
Enterprise Value 1.05B 916M 865M 785M 1.47B 101B 1.48B 10.36B 4B 51.23B 3.94B 3.86B 165B EV / Sales 2026 *
11.5x
EV / Sales 2027 * 10.4x
Free-Float
64.83%
Yield 2026 *
-
Yield 2027 * -
1 day-0.75%
1 week-0.12%
Current month-4.93%
1 month-6.04%
3 months-10.93%
6 months-17.76%
Current year-15.58%
1 week 81.5
Extreme 81.5
84.36
1 month 81.4
Extreme 81.405
89.13
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap. Importance
03/09/26 Sell

Director

-1,419 0.0111%
04/06/26 Sell

Director

-3,000 0.0235%
01/06/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-0.12%+16.45%+80.60% 1.05B
+0.70%-2.05%-31.71%-4.72% 12.32B
+0.74%+3.06%+13.39%+5.19% 4.27B
+2.43%-1.35%-44.85%-60.48% 1.2B
+2.10%-0.20%-42.48%-44.99% 1.06B
+3.85%+6.56%-36.79% - 1.02B
+2.69%+5.06% - - 1B
+3.03%+5.92%+37.90%+107.36% 518M
+5.85%+1.52%+41.35% - 335M
-0.06%-7.73%-70.92%+320.15% 226M
Average +2.06%+0.71%-13.07%+57.59% 2.3B
Weighted average by Cap. +1.14%+0.31%-19.78%+2.74%

Financials

2026 *2027 *
Net sales 91.2M 79.53M 75.09M 68.19M 128M 8.75B 128M 899M 347M 4.45B 343M 335M 14.32B 101M 88.07M 83.16M 75.52M 141M 9.69B 142M 996M 384M 4.93B 379M 371M 15.85B
Net income 24.65M 21.49M 20.3M 18.43M 34.53M 2.37B 34.68M 243M 93.82M 1.2B 92.6M 90.54M 3.87B 28.45M 24.81M 23.42M 21.27M 39.85M 2.73B 40.02M 281M 108M 1.39B 107M 104M 4.47B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
18/09/26 US$82.12 -0.75% 211,442
17/09/26 US$82.74 +0.19% 91,004
16/09/26 US$82.58 +0.21% 115,966
15/09/26 US$82.41 -0.15% 95,963
14/09/26 US$82.53 +0.38% 90,160
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
82.12USD
Average target price
118.00USD
Spread / Average Target
+43.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!